Subscribe To
Matinas BioPharma to Provide Corporate Update and 2023 Business Outlook on January 30, 2023
Conference call and live audio webcast scheduled for Monday, January 30th at 4:30 p.m. ET BEDMINSTER, N.J., Jan. 23, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage biopharmaceutical company focused on redefining the intracellular delivery of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform technology, today announced that the Company […] The post Matinas BioPharma to Provide Corporate Update and 2023 Business Outlook on January 30, 2023 a...
Read More
Posted: Jan 23 2023, 12:00
Author Name: forextv
Views: 102538